- Published at
- by manilatimes.net
mixed
mixed
News for Monte Rosa Therapeutics, Inc. (GLUE)
- Published at
- by gurufocus.com
neutralneutralMonte Rosa Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference
BOSTON, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. ( GLUE), a clinical-stage biotechnology company developing novel molecular glue degrad- Published at
- by seekingalpha.com
neutralneutralBullish On Monte Rosa Therapeutics' 'Undruggable' Targets With QuEEN (NASDAQ:GLUE)
One of Monte Rosa's main differentiating factors is its proprietary QuEEN platform to design new molecular glue degraders. Read why GLUE stock is a Buy.- Published at
- by gurufocus.com
positivepositiveAvoro Capital Advisors LLC Reduces Stake in Monte Rosa Therapeutics Inc
On December 31, 2024, Avoro Capital Advisors LLC (Trades, Portfolio) executed a notable transaction involving Monte Rosa Therapeutics Inc. The firm reduced its- Published at
- by gurufocus.com
negativenegativeMonte Rosa Therapeutics Provides Corporate Update and Key Anticipated Milestones for 2025
Initial clinical data from Phase 1 SAD/MAD study of VAV1-directed molecular glue degrader (MGD) MRT-6160 expected in Q1 2025 Additional clinical results from P- Published at
- by gurufocus.com
negativenegativeMonte Rosa Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
BOSTON, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. ( GLUE), a clinical-stage biotechnology company developing novel molecular glue degrad- Published at
- by manilatimes.net
neutralneutral- Published at
- by investing.com
mixedmixedMonte Rosa Therapeutics appoints new board member By Investing.com
Monte Rosa Therapeutics appoints new board member- Published at
- by gurufocus.com
neutralneutralMonte Rosa Therapeutics Appoints Dr. Eric A. Hughes to Board of Directors
BOSTON, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. ( GLUE), a clinical-stage biotechnology company developing novel molecular glue degrad- Published at
- by investing.com
negativenegativeMonte Rosa Therapeutics Announces Closing of Global License Agreement with Novartis to Advance T and B Cell-modulating VAV1-directed Molecular Glue Degraders By Investing.com
Monte Rosa Therapeutics Announces Closing of Global License Agreement with Novartis to Advance T and B Cell-modulating VAV1-directed Molecular Glue Degraders- Published at
- by manilatimes.net
negativenegative- Published at
- by gurufocus.com
negativenegativeMonte Rosa Therapeutics Announces Closing of Global License Agreement with Novartis to Advance T and B Cell-modulating VAV1-directed Molecular Glue Degraders
BOSTON, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. ( GLUE), a clinical-stage biotechnology company developing novel molecular glue degrad- Published at
- by gurufocus.com
neutralneutralMonte Rosa Therapeutics Provides Development Progress Update for Ongoing MRT-2359 Phase 1/2 Study in Patients with MYC-driven Solid Tumors
Results from dose escalation arms of Phase 1/2 study of MRT-2359 demonstrated a favorable safety profile and targeted levels of GSPT1 degradation using a 21 day- Published at
- by seekingalpha.com
mixedmixed- Published at
- by investing.com
mixedmixedMonte Rosa Therapeutics announces key leadership promotions By Investing.com
Monte Rosa Therapeutics announces key leadership promotions- Published at
- by benzinga.com
mixedmixedWhy Westport Fuel Systems Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session - Westport Fuel Systems (NASDAQ:WPRT)
Shares of Westport Fuel Systems Inc. (NASDAQ: WPRT) fell sharply during Tuesday’s session after posting a wider-than-expected fourth-quarter loss. Westport Fuel Systems posted a quarter loss of 81 cents per share, compared to market expectations for a loss of 51 cents per share.- Published at
- by seekingalpha.com
mixedmixed- Published at
- by globenewswire.com
mixedmixed- Published at
- by benzinga.com
mixedmixedStocks That Hit 52-Week Lows On Thursday
On Thursday, 615 stocks hit new 52-week lows. Noteable 52-Week Lows: Sea (NYSE:SE) is the largest company in terms of market cap to set a new ...ZYNETIGRRESNPRPONVTANTRANCTYLTRNLKCOJANHTBXGERNCZOOCVNACPNGCLVRCLOVCDNAAUVIAUUDAGRXADPTABOSZYMEYSGYMTXXLWKHSWISHWIMIVSTMVMEOVLDRVKTXVHCUPUNCYTYRATWLOTPSTTNGXTLSTDUPTDOCTAOPSURFSUNWSMFRSLGGSGBXSDCROVRROKURMORGLSRDUSRCKTQUREPYCRPWSCPOSHPLSEPINGPETSPBYIONCTOLOOLMANUVLNLSMYSZMVSTMTCRMRKRMORMILEMGNIMEDSLABPKERNIZEAISUNIRNTINOIGMSHGENHCWBHCATGTHGRAYEPZMENVBENGDOMADNMRDMTKDIBSDHDADACYRXCTSOCRDLCOCPCGCCEVACDXCCBIOCBATBYNDBWENBOLTBNRBNGOBLNDBLIBKTBKSYBILIBASEARTLAPPHAPDNAMWLALLKALGSAEYZMZHYMABXOSXNETWINTWATTWAFUVVPRVVNTVRNSVRMVLTAVISLVERUTYMETXGTWSTTTCFTSHATRKATPICTLRYTLISTENXTDFTCRRTALSYBXSUMOSTTKSTROSTABSRNESQSPSPWRSOSSNAPSLRXSLQTSLDBSKYTSKLZSIENSHLSSHCRSGTXSFTSEERSCPSSCPLSBTXSANARUNRDFNRCELRAASQTRXPTONPSTIPRVBPRTSPOLAPINSPHRPHATPGENPEGAPDDPCTPATHPASGPAICOZONOUSTOTRKOSCROPENOPADONVOOKTAODTOBSVNXTPNUVBNLTXNEOMVISMREOMQMNTSMBIOMASSLTCHLPROLFMDKNTEKLDOKCKALAJMIAIQINSGINMBINMIMRAICVXHYMCHUMAHOOKHOODHIPOGTHXGRWGGRILGOCOGLYCGLUEGHFUVFUBOFTEKFTCIFSLYFLDMFIXXEXASEVOKEOSEELYSEIGRECORDYNDUOLDTILDRRXDPRODOMODLODKNGDIDIDATSCSIQCRSPCRONCRISCOMPCMPSCLSKCALABXRXBLNKBLINBLDPBIGCBCELAYROAVTXAVROAVIRATAIAQMSAQBANGIAMRSALXOALVRALNAALFAIKIAEVAAERIADVMABSIABIOABCLAAOI